181 related articles for article (PubMed ID: 37845557)
21. Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.
Hsu C; Marshall JL; He AR
Oncologist; 2020 Feb; 25(2):105-111. PubMed ID: 32043797
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami C; Shin JS; Hammond NA; Kothari K; Mittal PK; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1371-1386. PubMed ID: 31493022
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors.
Yoshikawa Y; Imamura M; Yamauchi M; Hayes CN; Aikata H; Okamoto W; Miyata Y; Okada M; Hattori N; Sugiyama K; Yoshioka Y; Toratani S; Takechi M; Ichinohe T; Ueda T; Takeno S; Kobayashi T; Ohdan H; Teishima J; Hide M; Nagata Y; Kudo Y; Iida K; Chayama K
BMC Cancer; 2022 Nov; 22(1):1232. PubMed ID: 36447159
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Pancreatic Injury and Pancreatitis in Patients Treated With Immune Checkpoint Inhibitors.
Hori Y; Naitoh I; Naiki-Ito A; Kawai T; Yoshida M; Kato A; Kachi K; Sahashi H; Adachi A; Toyohara T; Kito Y; Yamamoto T; Takahashi S; Kataoka H
Clin Transl Gastroenterol; 2024 Apr; 15(4):e00667. PubMed ID: 38088372
[TBL] [Abstract][Full Text] [Related]
25. Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.
Poto R; Troiani T; Criscuolo G; Marone G; Ciardiello F; Tocchetti CG; Varricchi G
Front Immunol; 2022; 13():804597. PubMed ID: 35432346
[TBL] [Abstract][Full Text] [Related]
26. Clinical management of autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2007; 52():61-5. PubMed ID: 18217391
[TBL] [Abstract][Full Text] [Related]
27. Duct-obstructive pancreatitis with granulocytic epithelial lesion in a patient with ulcerative colitis: An atypical manifestation of type 2 autoimmune pancreatitis?
Ahn S; Lee JC; Hwang JH; Yoon YS; Lee KH; Zen Y
Pathol Int; 2019 Jul; 69(7):420-426. PubMed ID: 31219205
[TBL] [Abstract][Full Text] [Related]
28. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors.
Townsend MJ; Benque IJ; Li M; Grover S
Aliment Pharmacol Ther; 2024 Jun; 59(11):1350-1365. PubMed ID: 38590108
[TBL] [Abstract][Full Text] [Related]
29. Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency.
Barresi L; Tacelli M; Crinò SF; Attili F; Petrone MC; De Nucci G; Carrara S; Manfredi G; Capurso G; De Angelis CG; Crocellà L; Fantin A; Dore MF; Garribba AT; Tarantino I; De Pretis N; Pagliari D; Rossi G; Manes G; Preatoni P; Barbuscio I; Tuzzolino F; Traina M; Frulloni L; Costamagna G; Arcidiacono PG; Buscarini E; Pezzilli R;
United European Gastroenterol J; 2020 Jul; 8(6):705-715. PubMed ID: 32397913
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival.
Yamada K; Sawada T; Nakamura M; Yamamura T; Maeda K; Ishikawa E; Iida T; Mizutani Y; Kakushima N; Ishikawa T; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Furune S; Hase T; Yokota K; Maeda O; Hashimoto N; Akiyama M; Ando Y; Fujishiro M
World J Gastroenterol; 2021 Nov; 27(41):7190-7206. PubMed ID: 34887637
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune pancreatitis: an update.
Khandelwal A; Inoue D; Takahashi N
Abdom Radiol (NY); 2020 May; 45(5):1359-1370. PubMed ID: 31650376
[TBL] [Abstract][Full Text] [Related]
32. Corticosteroids prevent the progression of autoimmune pancreatitis to chronic pancreatitis.
Kuraishi Y; Uehara T; Watanabe T; Ashihara N; Ozawa M; Kanai K; Kawa S
Pancreatology; 2020 Sep; 20(6):1062-1068. PubMed ID: 32800575
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors.
Yao L; Jia G; Lu L; Bao Y; Ma W
Int Immunopharmacol; 2020 Aug; 85():106628. PubMed ID: 32474388
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus.
Liao D; Liu C; Chen S; Liu F; Li W; Shangguan D; Shi Y
Int Immunopharmacol; 2023 Sep; 122():110414. PubMed ID: 37390646
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune Pancreatitis: From Pathogenesis to Treatment.
Nista EC; De Lucia SS; Manilla V; Schepis T; Pellegrino A; Ojetti V; Pignataro G; Zileri Dal Verme L; Franceschi F; Gasbarrini A; Candelli M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293522
[TBL] [Abstract][Full Text] [Related]
36. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
Am J Surg Pathol; 2011 Jan; 35(1):26-35. PubMed ID: 21164284
[TBL] [Abstract][Full Text] [Related]
37. The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis.
de Pretis N; Amodio A; De Marchi G; Marconato E; Ciccocioppo R; Frulloni L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1119-1124. PubMed ID: 36125384
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.
Xiang P; Zhang X; Wang C; Lang Y; Xu L; Huang L; Shen J; Feng ST
BMC Cancer; 2019 Aug; 19(1):814. PubMed ID: 31419961
[TBL] [Abstract][Full Text] [Related]
39. Strategy to differentiate autoimmune pancreatitis from pancreas cancer.
Takuma K; Kamisawa T; Gopalakrishna R; Hara S; Tabata T; Inaba Y; Egawa N; Igarashi Y
World J Gastroenterol; 2012 Mar; 18(10):1015-20. PubMed ID: 22416175
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune pancreatitis not otherwise specified (NOS): Clinical features and outcomes of the forgotten type.
de Pretis N; Vieceli F; Brandolese A; Brozzi L; Amodio A; Frulloni L
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):576-579. PubMed ID: 31248720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
